Nerve ultrasound, neuronopathy and cough predict sensory neuropathy patients with <i>RFC1</i> expansions

The finding of biallelic pathogenic pentanucleotide <i>RFC1</i> expansions has extended the spectrum of disease in cerebellar ataxia, neuropathy and vestibular areflexia syndrome. It is clear that for many, a sensory neuropathy is an early feature and raises the question of how to identify which patients with this common neurophysiological presentation should be tested genetically for the condition. We identified patients with idiopathic, sensory predominant neuropathies who had attended the Neurophysiology Department of Auckland Hospital for nerve conduction studies. We undertook a systematic clinical re-evaluation to test whether any of the following hypothesized variables distinguish the presence of pathogenic <i>RFC1</i> expansions. These were (i) chronic cough, (ii) ataxia, (iii) pure sensory changes on nerve conduction, (iv) a non-length-dependent pattern of sensory loss on nerve conduction studies, (v) small nerves on peripheral nerve ultrasound, (vi) bilateral vestibular dysfunction and (vii) autonomic dysfunction. We recruited 53 patients, of whom 10 had normal repeat nerve conductions. Among the 43 (25 males, 18 females) remaining patients, five were positive for the pathogenic <i>RFC1</i> expansions. All five reported a chronic cough (versus 4/38 <i>RFC1</i>-negative cases, <i>P</i> = 0.0002). None of the five cases had abnormal motor findings (versus 20/37 <i>RFC1</i>-negative cases, <i>P</i> = 0.07). Four of the five cases had small (<5.2 mm<sup>2</sup>) mean upper limb nerves by cross-sectional area on ultrasound (versus 2/38 <i>RFC1</i>-negative cases, <i>P</i> = 0.0006). The fifth had concurrent diabetes, which might explain their normal sized nerves. Four of the five cases had a non-length-dependent sensory neuropathy, and one had a length-dependent sensory neuropathy. The <i>RFC1</i>-positive case with a length-dependent neuropathy had small upper limb nerves on ultrasound. There were no differences in ataxia scores between the groups, and only two <i>RFC1</i>-positive cases had vestibular involvement. Two of the five <i>RFC1</i>-positive cases, both Sāmoan, had a novel arrangement in their <i>RFC1</i> expansion in which the pathogenic AAGGG expansion was preceded by a short AAAAG expansion. Taken together, in this small sample, the presence of a chronic cough with either a non-length-dependent neuropathy on nerve conduction studies or a mean upper limb nerve cross-sectional area <5.2 mm<sup>2</sup> was strongly associated with the <i>RFC1</i> expansion (sensitivity 100%, specificity 97%). Patients who fit these criteria should be tested genetically for <i>RFC1</i>. Ultrasound and nerve conduction studies should be seen as complementary in the workup of patients for <i>RFC1</i> expansions.

Authors

Institutions

Publication Details

Journal
Brain Communications
Published
2025-01-01
DOI
https://doi.org/10.1093/braincomms/fcaf434
Citations
1
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.91
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nerve ultrasound, neuronopathy and cough predict sensory neuropathy patients with RFC1 expansions

Carolin K. Scriba, Chongyang Ren, Vivien Yong, Luciana Pelosi et al.
1 citations
Brain Communications
Genetic Neurodegenerative Diseases
0.91
article

Nerve ultrasound, neuronopathy and cough predict sensory neuropathy patients with RFC1 expansions

Carolin K. Scriba, Chongyang Ren, Vivien Yong, Luciana Pelosi, Nigel G. Laing, Richard H Roxburgh, J. Caldwell, Chirag Patel, Melanie Glenn, Gianina Ravenscroft, Rachael L. Taylor, Thomas Chang, Justin Kao, I. Zay Melville, Miriam Rodrigues, Anthony Garvey
article en
1 citations

Abstract

The finding of biallelic pathogenic pentanucleotide <i>RFC1</i> expansions has extended the spectrum of disease in cerebellar ataxia, neuropathy and vestibular areflexia syndrome. It is clear that for many, a sensory neuropathy is an early feature and raises the question of how to identify which patients with this common neurophysiological presentation should be tested genetically for the condition. We identified patients with idiopathic, sensory predominant neuropathies who had attended the Neurophysiology Department of Auckland Hospital for nerve conduction studies. We undertook a systematic clinical re-evaluation to test whether any of the following hypothesized variables distinguish the presence of pathogenic <i>RFC1</i> expansions. These were (i) chronic cough, (ii) ataxia, (iii) pure sensory changes on nerve conduction, (iv) a non-length-dependent pattern of sensory loss on nerve conduction studies, (v) small nerves on peripheral nerve ultrasound, (vi) bilateral vestibular dysfunction and (vii) autonomic dysfunction. We recruited 53 patients, of whom 10 had normal repeat nerve conductions. Among the 43 (25 males, 18 females) remaining patients, five were positive for the pathogenic <i>RFC1</i> expansions. All five reported a chronic cough (versus 4/38 <i>RFC1</i>-negative cases, <i>P</i> = 0.0002). None of the five cases had abnormal motor findings (versus 20/37 <i>RFC1</i>-negative cases, <i>P</i> = 0.07). Four of the five cases had small (<5.2 mm<sup>2</sup>) mean upper limb nerves by cross-sectional area on ultrasound (versus 2/38 <i>RFC1</i>-negative cases, <i>P</i> = 0.0006). The fifth had concurrent diabetes, which might explain their normal sized nerves. Four of the five cases had a non-length-dependent sensory neuropathy, and one had a length-dependent sensory neuropathy. The <i>RFC1</i>-positive case with a length-dependent neuropathy had small upper limb nerves on ultrasound. There were no differences in ataxia scores between the groups, and only two <i>RFC1</i>-positive cases had vestibular involvement. Two of the five <i>RFC1</i>-positive cases, both Sāmoan, had a novel arrangement in their <i>RFC1</i> expansion in which the pathogenic AAGGG expansion was preceded by a short AAAAG expansion. Taken together, in this small sample, the presence of a chronic cough with either a non-length-dependent neuropathy on nerve conduction studies or a mean upper limb nerve cross-sectional area <5.2 mm<sup>2</sup> was strongly associated with the <i>RFC1</i> expansion (sensitivity 100%, specificity 97%). Patients who fit these criteria should be tested genetically for <i>RFC1</i>. Ultrasound and nerve conduction studies should be seen as complementary in the workup of patients for <i>RFC1</i> expansions.

Brain CommunicationsVol. 7(6)
University of Auckland (NZ), The University of Western Australia (AU), Auckland City Hospital (NZ), Dunedin Public Hospital (NZ), Queen Elizabeth II Medical Centre (AU), Tauranga Hospital (NZ), Brain Research New Zealand (NZ)
Openalex Percentile: Top 21%
Genetic Neurodegenerative Diseases
0.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.